Company CVAbout Shree Ganesh Remedies Ltd 
Shree Ganesh Remedies Ltd
Micro Cap
Pharmaceuticals & Drugs
Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name "Shree Ganesh Remedies Private Limited" at Ahmedabad, Gujarat on April 27, 1995. Subsequently the Company was converted into a Public Limited and the name of the Company was changed to "Shree Ganesh Remedies Limited" on July 28, 2017. The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals.
Company Coordinates
Company Details
Plot No 6011, GIDC Ankleshwar Gujarat : 393002
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 12.84 Cr
Number of Shares
1.28 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
09-Jul-2024
1.28
12.84
1730
10
Rights Partly Paid to Fully Paid Up
23-Apr-2024
1.28
12.83
828195
10
Rights Partly Paid to Fully Paid Up
03-Feb-2023
1.28
12.85
840471
10
Right Issues
01-Nov-2021
1.2
12.01
2000281
10
Bonus Issue
06-Oct-2020
1
10.01
1035090
10
Bonus Issue
13-Oct-2017
89.71
8.97
2376000
10
Public Issues
11-Oct-2017
89.71
8.97
2376000
10
Public Issue
24-Aug-2017
65.95
6.60
5496130
10
Bonus
24-Aug-2017
65.95
6.60
5496130
10
Bonus Issue
31-Mar-2012
10.99
1.10
69494
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 1 FIIs (0.01%)
Promoter with highest holding
Chandulal Manubhai Kothia (48.76%)
Highest Public shareholder
Gunjan Jayantibhai Dhorajiya (1.71%)
Individual Investors Holdings
24.88%
Board of Directors
Management
Designation
Remuneration
Chandubhai Kothia
Chairman & Managing Director
1.02 cr
Gunjan Chandulal Kothia
Whole-time Director
51.0 lacs
Parth Chandulal Kothia
Whole-time Director
42.0 lacs
Priyam Surendra Shah
Independent Director
30.0 k
Jayesh Savjani
Independent Director
30.0 k
Vaishaliben Kanjibhai Vadodariya
Independent Director
30.0 k
Parul Sahani
Director
0
Maulikkumar Sudani
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Packing Material Consumed
0.4559
0%
Packing Material Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drug Intermediates
35.31
100.00%
Bulk Drug Intermediates
Stock DNARevenue and Profits:
Net Sales:
27 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
Pharmaceuticals & Drugs
INR 900 Cr (Micro Cap)
30.00
33
0.00%
0.09
21.85%
6.60
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
